Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator

Rh4 may serve as a novel AMPK activator to protect against hyperlipidaemia-induced endothelial dysfunction, providing new insights into the prevention and treatment of endothelial injury-associated CVD.